Globus Medical (GMED)

Profitability ratios

Return on sales

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Gross profit margin 55.35% 54.53% 57.00% 60.57% 65.05% 71.19% 74.17% 74.24% 74.22% 74.47% 74.54% 74.68% 75.03% 74.69% 74.48% 72.92% 72.44% 73.23% 74.09% 76.42%
Operating profit margin 8.52% 6.64% 5.22% 6.26% 8.49% 14.44% 21.55% 22.26% 22.29% 19.24% 19.07% 17.04% 17.95% 22.55% 22.52% 16.65% 14.12% 13.41% 12.70% 20.60%
Pretax margin 4.79% 4.88% 2.98% 4.93% 10.54% 16.51% 23.83% 24.07% 23.76% 20.11% 19.89% 17.90% 18.83% 23.66% 23.87% 18.24% 15.96% 15.40% 14.95% 22.80%
Net profit margin 4.09% 3.69% 1.82% 3.51% 7.83% 12.87% 18.63% 18.82% 18.59% 15.55% 15.91% 14.77% 15.57% 19.87% 19.83% 14.73% 12.96% 12.36% 11.90% 18.66%

Globus Medical's profitability ratios have displayed some fluctuations over the years.

1. Gross Profit Margin: Globus Medical's gross profit margin has shown a gradual decline from 76.42% on March 31, 2020, to 55.35% on December 31, 2024. This indicates a decrease in the percentage of revenue that the company retains after accounting for the cost of goods sold.

2. Operating Profit Margin: The operating profit margin of Globus Medical has seen fluctuations, with a peak of 22.55% on September 30, 2021, and a low of 5.22% on June 30, 2024. This ratio reflects the company's ability to generate profits from its core operations.

3. Pretax Margin: Globus Medical's pretax margin has fluctuated over the years, with a peak of 24.07% on March 31, 2023, and a low of 2.98% on June 30, 2024. This ratio represents the company's profitability before taxes are deducted.

4. Net Profit Margin: The net profit margin of Globus Medical has also experienced variations, ranging from 18.82% on March 31, 2023, to 1.82% on June 30, 2024. This ratio reflects the company's profitability after all expenses, including taxes, are deducted.

Overall, the trend in the profitability ratios of Globus Medical suggests some volatility, pointing to potential challenges in maintaining consistent levels of profitability over the analyzed period. It may be essential for the company to focus on cost management and operational efficiency to improve its overall profitability in the future.


Return on investment

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating return on assets (Operating ROA) 4.09% 3.23% 2.34% 2.40% 2.62% 3.31% 10.68% 11.07% 10.98% 9.72% 9.70% 8.20% 8.79% 11.11% 11.42% 7.91% 6.63% 6.67% 6.48% 11.04%
Return on assets (ROA) 1.96% 1.80% 0.81% 1.35% 2.42% 2.95% 9.24% 9.36% 9.16% 7.85% 8.09% 7.10% 7.62% 9.79% 10.06% 7.00% 6.09% 6.15% 6.07% 10.00%
Return on total capital 6.20% 6.41% 7.03% 7.62% 6.84% 6.13% 12.48% 13.01% 13.00% 11.59% 11.75% 9.97% 10.57% 12.71% 13.14% 9.03% 7.67% 7.54% 7.47% 12.33%
Return on equity (ROE) 2.47% 2.25% 1.02% 1.70% 3.07% 3.77% 10.29% 10.51% 10.30% 8.80% 9.12% 7.95% 8.57% 10.89% 11.23% 7.78% 6.79% 6.69% 6.65% 10.85%

Globus Medical's profitability ratios have shown fluctuations over the years. The Operating Return on Assets (Operating ROA) increased from 6.48% in June 2020 to a peak of 11.42% in June 2021, before gradually declining to 3.23% by September 2024.

The Return on Assets (ROA) followed a similar pattern, peaking at 10.06% in June 2021 before dropping significantly to 0.81% in June 2024.

Return on Total Capital peaked at 13.14% in June 2021, also showing a decline to 6.20% by December 2024.

Return on Equity (ROE) experienced a peak of 11.23% in June 2021 but declined to 1.02% by June 2024.

These ratios indicate that Globus Medical's profitability has varied over time, with fluctuations in the efficiency of asset utilization, capital management, and equity returns. Further analysis of the company's financial performance and operational strategies could provide insights into the underlying factors influencing these trends.